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OBJECTIVE — The relationship between increased arterial stiffness and cardiovascular mor-
tality is well established in type 2 diabetes. We examined whether aerobic exercise could reduce
arterial stiffness in older adults with type 2 diabetes complicated by comorbid hypertension and
hyperlipidemia.
RESEARCH DESIGN AND METHODS — A total of 36 older adults (mean age 71.4 
0.7 years) with diet-controlled or oral hypoglycemic–controlled type 2 diabetes, hypertension,
and hypercholesterolemia were recruited. Subjects were randomly assigned to one of two
groups: an aerobic group (3 months vigorous aerobic exercise) and a nonaerobic group (no
aerobicexercise).Exercisesessionsweresupervisedbyacertiﬁedexercisetrainerthreetimesper
week, and a combination of cycle ergometers and treadmills was used. Arterial stiffness was
measured using the Complior device.
RESULTS — When the two groups were compared, aerobic training resulted in a decrease in
measures of both radial (20.7  6.3 vs. 8.5  6.6%, P  0.005) and femoral (13.9  6.7
vs.4.43.3%,P0.015)pulse-wavevelocitydespitethefactthataerobicﬁtnessasassessed
by VO2max did not demonstrate an improvement with training (P  0.026).
CONCLUSIONS — Ourﬁndingsindicatethatarelativelyshortaerobicexerciseintervention
in older adults can reduce multifactorial arterial stiffness (type 2 diabetes, aging, hypertension,
and hypercholesterolemia).
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T
he normal aging process is associ-
ated with an increase in vascular
stiffness (1), a process that is accel-
erated by the presence of type 2 diabetes
(2), hypercholesterolemia (3), and hy-
pertension (4). The relationship be-
tween increased arterial stiffness and
cardiovascular mortality is well estab-
lished (5). Exercise has successfully
reduced vascular stiffness in young pop-
ulations (6), suggesting that it could be
used in older adults with type 2 diabetes
complicated by other cardiovascular risk
factors.
Previous cross-sectional studies have
shown that older adults who engage in
regular aerobic exercise training have
lower arterial stiffness than sedentary
older adults (7). Prospective examina-
tions of a moderate aerobic exercise pro-
gram in middle-aged subjects with type 2
diabetes (6) and normal older adults (7)
have demonstrated a decrease in arterial
stiffness. In fact, even brief aerobic inter-
ventions in healthy middle-aged men
have demonstrated a direct impact on ar-
terial compliance without any effect on
cholesterol, blood pressure, body weight,
or resting heart rate (7). It has been hy-
pothesized that mechanical distension
during aerobic exercise sessions results in
pulsatile“stretching”ofthecollagenﬁbers
that reverses the glycation-related colla-
gen cross-linking that is responsible for
reduced arterial compliance in diabetes
(8). The impact of aerobic exercise on ar-
terial stiffness in older adults with exten-
sive vascular damage due to multiple
etiologies (type 2 diabetes, hypercholes-
terolemia, and hypertension) has not
been examined previously.
In the current study, we examined
whether aerobic exercise can reverse arte-
rial stiffness in adults at very high cardio-
vascular risk (long-standing diabetes,
geriatric age-group, hypercholesterol-
emia, and hypertension). We hypothe-
sized that despite these multifactorial
reasons for reduced arterial compliance,
aerobic exercise would be an effective
nonpharmacological therapy for in-
creased arterial stiffness.
RESEARCH DESIGN AND
METHODS— Forty older adults (21
menand19women,meanage71.40.7
years,agerangefrom65to83years)were
recruited from the local community
through advertisement in local publica-
tions(Table1).Allsubjectshadtobeaged
65 years and were excluded if they had
any history of angina, myocardial infarc-
tion, stroke, chronic pulmonary disease,
were current smokers, or had exercise-
limitingorthopedicimpairment.Allolder
subjects were required to have type 2 di-
abetes for at least 5 years, hypertension,
and hyperlipidemia. Hypertension, dia-
betes, and hyperlipidemia were deﬁned
bycurrentAmericanDiabetesAssociation
guidelines (9). Hypertension was deﬁned
as taking antihypertensive agents or hav-
ing an average blood pressure (based on
the mean of three measurements) with a
systolic blood pressure 130 mmHg or a
diastolic blood pressure 80 mmHg (9).
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-blockers, calcium channel blockers, or
any other agent that inﬂuenced autonomic
function. Entry requirements included a
normal resting electrocardiogram, a nor-
malBruceprotocoltreadmillmaximalex-
ercise stress test, a normal hematocrit,
and a normal creatinine level. Subjects
had to be sedentary at the start of the
study (as deﬁned as no strength training
and30minbriskwalking/moderateex-
ercise per week and no vigorous exercise
inthepreceding6months).Foursubjects
wereexcluded(twomaleandtwofemale)
on the basis of this screening, leaving a
total of 36 subjects participating in the
study. Eighteen subjects were randomly
assignedtoeachoftwogroups:anaerobic
groupandanonaerobicgroup.Allocation
concealment was maintained through the
use of an off-site randomized list, man-
agedbyanindividualwhohadnocontact
with subjects before completion of re-
cruitment and screening. This study was
approved by the Human Subjects Com-
mittee of the University of British Colum-
bia, and all subjects gave written informed
consent.
Each subject underwent two evalua-
tionsessionsbeforeandafterthe3-month
intervention. Postintervention study ses-
sions could be delayed up to 7 days to
accommodateeachsubject’sschedule.All
study sessions were performed with the
subject supine and took place between
7:00 A.M. and noon for all subjects to
avoid bias due to circadian rhythms. The
technician responsible for performing all
measures was blinded to subject group.
Training program
The endurance training (aerobic group)
intervention was designed to improve
aerobic ﬁtness according to current
guidelines(10)andconsistedofmoderate
to vigorous intensity exercise on a tread-
mill and a cycle ergometer. Training ses-
sions were conducted three times per
week, and subjects had to attend 90% of
all training sessions to remain enrolled in
the study. The aerobic training sessions
were 60 min in duration and consisted of
a10-minwarm-up,40minofaerobictrain-
ing, and 10 min of cool down/stretching. A
clinical exercise physiologist supervised
each class and veriﬁed compliance with the
exercise regimen. Moderate to vigorous in-
tensityexercisewasattainedviacontinuous
monitoring of heart rates (Polar Vantage
Heart Watches; Pursuit Performance, Ad-
elaide,Australia).Basedontherestingheart
rate and maximal heart rate determined
during maximal exercise treadmill testing
(see below), we set the training heart rate to
60–75% of heart rate reserve based on the
Karvonen formula (11).
Subjects in the nonaerobic group also
attended sessions three times per week.
The nonaerobic group sessions were spe-
ciﬁcallydesignedtohavenoaerobiccom-
ponent and consisted of nonaerobic core
(exercise ball) and strength training
(dumbbells) exercises. We conﬁrmed a
lack of aerobic training in the nonaerobic
group with a test of maximal oxygen con-
sumption in each subject(VO2max, see be-
low). The trainer also contacted each
subject weekly to ensure that he or she
was not undertaking any additional exer-
cise.Forethicalreasons,allsubjectsinthe
nonaerobic group was given the option of
joining the aerobic exercise group after
the 3-month intervention period was
complete to encourage them to increase
their level of physical ﬁtness.
Exercise classes were held in a hospi-
tal-basedfacility(HealthyHeartProgram,
St. Paul’s Hospital, Vancouver, BC, Can-
ada) under the supervision of clinical ex-
ercise physiologists with cardiology and
emergency services available. Cardiovas-
cular measurements were taken before,
during, and after exercise and included
blood pressure, heart rate, and blood glu-
cose. Electrocardiogram telemetry was
also available, if necessary, when unusual
heart rates or rhythms were noted.
Data collection and processing
Subject conditions were standardized ac-
cordingtoestablishedguidelines:allmea-
surementswereperformedafter30minof
supine rest, the environment was quiet
and temperature controlled (25  1°C),
all subjects were fasting, and all subjects
had refrained from consumption of alco-
hol or caffeine for the preceding 24 h. To
avoid the confounding acute effects of ex-
ercise, the aerobic training program was
also halted for the preceding 24 h (12).
Arterial stiffness was measured using the
Compliordevice(ArtechMedical,Pantin,
France), a semiautomated device that
uses two pressure transducers (12). The
pressure transducers are held in place by
Velcro straps that allow them be ﬁxed
over the skin. Each pressure transducer
measures the pulse-wave form at each
site, allowing one to measure transit time
of the pulse wave between the two loca-
tions. A higher pulse-wave velocity
(PWV) represents greater arterial stiff-
ness. The transducers are placed over the
carotid and femoral arteries for a measure
of central arterial stiffness and over the
carotidandradialarteriesforameasureof
peripheral arterial stiffness (12). PWV
was calculated from these transducer
measures, which are digitally recorded
(sampling rate 500 Hz), resulting in mea-
sures of radial and femoral PWV. PWV
waschosenasourmeasureofarterialstiff-
ness because it is the most commonly
usedmeasurebothintheliteratureandin
consensusstatements(13).FemoralPWV
is also one of the only indexes of arterial
stiffness directly linked with cardiovascu-
lar mortality and morbidity (14).
Heart rate, systolic blood pressure
(SBP), diastolic blood pressure (DBP),
and mean (MAP) blood pressure were
Table 1—Subject characteristics
All subjects AT subjects NA subjects P
Age (years) 71.4  0.7 71.7  1.1 71.1  0.9 0.417
Weight (kg) 80.3  2.1 81.9  2.2 79.3  3.1 0.554
Height (cm) 167.6  1.5 165.4  2.1 169.0  2.1 0.263
BMI (kg/m
2) 28.6  0.64 30.1  1.1 27.7  1.0 0.064
Waist-to-hip ratio 0.95  0.01 0.96  0.02 0.94  0.02 0.315
SBP (mmHg) 143  3 150  6 139  4 0.149
DBP (mmHg) 85  28 3  28 6  2 0.329
MAP (mmHg) 104  2 105  3 104  3 0.723
Heart rate (bpm) 66.0  2.2 66.8  4.1 65.3  2.3 0.744
Fasting blood glucose (mEq) 7.5  0.3 7.9  0.6 7.1  0.3 0.22
A1C (%) 6.5  0.1 6.7  0.2 6.4  0.1 0.432
Total cholesterol (mmol/l) 4.7  0.2 5.0  0.2 4.6  0.3 0.290
LDL cholesterol (mmol/l) 2.6  0.2 2.6  0.8 2.5  0.2 0.592
HDL cholesterol (mmol/l) 1.5  0.1 1.5  0.1 1.5  0.1 0.619
Radial PWV (m/s) 10.08  0.34 10.41  0.58 9.65  0.60 0.368
Femoral PWV (m/s) 11.97  0.44 12.68  0.76 11.17  0.75 0.163
DataaremeansSEM.Demographicdataforaerobicallytrained(AT),untrained(NA),andallsubjects.P
0.05 was considered signiﬁcant.
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sure cuff (BpTRU Medical Devices, Co-
quitlam, BC, Canada). Each subject’s
weight was measured using a physician’s
balance scale. BMI, waist circumference,
hip circumference, and waist-to-hip ratio
were measured and calculated as per es-
tablished guidelines (15). VO2max was de-
terminedusingamaximalBrucetreadmill
protocol exercise test. The change in
VO2max was examined in all groups, in-
cluding the untrained and strength-
trained subjects.
Statistical analysis
All data analysis was done in a blinded
fashion.Resultsareexpressedasmeans
SEM.Oursamplesizecalculationsforour
three primary outcome measures (radial
PWV, femoral PWV, and VO2max)a s -
sumed a power of 90% and a 1.66% level
of signiﬁcance (after a Bonferroni correc-
tionformultiplecomparisons).Wefound
that we required a sample size of at least
15 subjects to detect a 15% difference in
our primary outcome measures. The ef-
fects of training on all measures were cal-
culated by a two-way ANOVA for
repeated measures (time  group). The
interactionofsexwithtrainingeffectswas
examined by a three-way ANOVA for re-
peated measures (time  group  sex)
(16). A value of P  0.0166 was consid-
ered signiﬁcant, because of a Bonferroni
correctionformultiplecomparisons(16).
Dropouts were handled on an intention-
to-treat basis.
RESULTS
Subject characteristics
There were two dropouts from the study,
one from each group (a total of 34 sub-
jects completed the intervention). One
dropout (aerobic group) was handled on
an intent-to-treat basis, whereas the other
(nonaerobic group) was lost to follow-up.
Other than the dropouts mentioned above,
all of the remaining 34 subjects attended at
least 90% of the training sessions. There-
fore,17subjectsfromtheaerobicgroupand
17 from the nonaerobic group completed
theintervention.AsshowninTable1,atthe
time of entry into the study, there was no
signiﬁcant difference between aerobic and
nonaerobic group subjects with respect to
demographicdata,restingheartrate,resting
bloodpressure,fastingbloodglucose,A1C,
or lipid proﬁle.
Effects of training on measures of
arterial stiffness
As shown in Fig. 1, aerobic training re-
sulted in a decrease in both radial (P 
0.005)andfemoral(P0.015)PWVthat
was not demonstrated in the nonaerobic
group.Infact,aerobictrainingresultedin
an	20.76.3%decreaseinradialPWV
and a 13.9  6.7% decrease in femoral
PWV over 3 months. In comparison, the
nonaerobicgroupdemonstratedan8.5
6.6% increase in radial PMV and a 4.4 
3.3% increase in femoral PWV.
Male subjects in the aerobic group
demonstrated a 25.5  9.8% decrease in
radialPMVanda15.17.7%decreasein
femoral PWV, whereas female subjects in
the aerobic training group demonstrated
an 18.6  8.3% decrease in radial PMV
and a 12.6  6.6% decrease in femoral
PWV.Inthenonaerobicgroup,malesub-
jects demonstrated a 9.0  11.0% in-
crease in radial PMV and an 11.5 
11.0% increase in femoral PWV; female
subjects in the nonaerobic group demon-
strated an 4.1  10.5% decrease in radial
PMV and a 1.8  2.3% increase in femo-
ral PWV. There was no signiﬁcant inter-
action of sex (time  group  sex) with
the effects of training on radial (P 
0.731) and femoral (P  0.260) PWV.
Effects of training on measures of
ﬁtness
The 3-month training program did not
result in a signiﬁcant increase in VO2max
(Fig.2)(P0.026).AsshowninTable2,
there was no signiﬁcant difference be-
tween the nonaerobic and aerobic groups
with respect to changes in weight (P 
0.942), BMI (P  0.396), waist-to-hip ra-
tio (P  0.786), or fasting blood glucose
(P  0.098). There was no signiﬁcant dif-
ference between the two groups with re-
specttochangesinSBP(P0.171),MAP
(P  0.078), DBP (P  0.091), or resting
heart rate (P  0.073). There was also no
signiﬁcant interaction of sex (time 
group  sex) with the effects of training on
weight, BMI, blood pressure, baseline heart
rate, and fasting blood glucose (Table 2).
CONCLUSIONS — Aerobic training
reversedmultifactorial(geriatricage,type
2 diabetes, hypertension, and hypercho-
lesterolemia) arterial stiffness, as shown
bysigniﬁcantdecreasesinbothradialand
femoral PWV. Improvements in arterial
stiffness occurred with only 3 months of
aerobic training despite the fact that this
was in a population at quite high cardio-
vascular risk. Interestingly, this improve-
ment occurred without any signiﬁcant
improvements in aerobic ﬁtness, weight,
BMI, waist-to-hip ratio, or blood pres-
sure.Thisﬁndingindicatesthattheeffects
ofaerobictrainingonthevasculaturemay
be independent of these other well-
established beneﬁts of exercise.
Previous work on the effects of aero-
bic exercise on arterial compliance has
consisted of cross-sectional data (7), pro-
Figure 1—Aerobic training (AT, f) resulted in a decrease in both radial PWV (rPWV) (P 
0.005) and femoral PWV (fPWV) (P  0.015) that was not demonstrated in the nonaerobic (NA,
 ) group.
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(6),andprospectiveinterventionsinmid-
dle-aged heathy persons (17). Cross-
sectional studies of older healthy adults
haveshownthatthosewhoperformregular
aerobic exercise have lower arterial stiffness
than sedentary older adults (7). High-
intensity exercise (running, 6 weeks) has
been shown to reduce arterial stiffness pro-
spectivelyinyoungathletes(6).Moremod-
eratetraining(dailywalking,3months)has
been shown prospectively to improve arte-
rial compliance in middle-aged healthy
women by 	40%, similar to the present
study (17). Congruent with the results of
the present study, brief (3 months of walk-
ing) aerobic interventions in healthy mid-
dle-aged men (mean age 52 years) have
demonstratedreductionsinarterialstiffness
without any effect on cholesterol, blood
pressure, body weight, or resting heart rate
(7).Acombinednutritionandwalkingpro-
gram (18) as well as a pure walking inter-
vention (6) have also demonstrated
prospectively a decrease in arterial stiffness
in the middle-aged type 2 diabetic popula-
tion. To our knowledge, our study is the
ﬁrsttoshowthateveninolderadultsatvery
high cardiovascular risk due to type 2 dia-
betes, age, hypertension, and hypercholes-
terolemia arterial stiffness can be reduced
with regular aerobic exercise.
The normal aging process is associ-
ated with an increase in vascular stiffness
(19), a process that is accelerated by the
presence of type 2 diabetes (2). The nor-
mal process of aging is known to result in
increased arterial stiffness because of an
increase in intima and media thickness,
smooth muscle cell hyperplasia, and ex-
tracellular matrix proliferation. Diabetes
has been shown to accelerate this age-
associated stiffening (20) mainly through
nonenzymatic glycation, the reaction be-
tween glucose and the extracellular
matrix proteins in the arterial wall. Non-
enzymatic glycation leads to the forma-
tion of increased collagen crosslinks that
resultinincreasedarterialstiffness(21).It
has been theorized that pulsatile stretch-
ing of collagen ﬁbers during aerobic exer-
cise can break these collagen crosslinks,
resulting in a decrease in arterial stiffness
(8). Interestingly, the fact that we did not
demonstrate a signiﬁcant change in
VO2max suggests that this decrease in arte-
rialstiffnesscanoccurevenintheabsence
of an improvement in overall aerobic ﬁt-
ness (Fig. 2). Aerobic exercise has also
been shown to increase arterial elastin
content and decrease calcium content in
rats (22), although the role for this mech-
anism in humans remains uncertain and
isunlikelytobeafactorduringa3-month
intervention.
Clinical implications
In persons with diabetes, previous re-
search has strongly established the rela-
tionship between vascular stiffness and
cardiovascular mortality (5). Our study
population consisted of older subjects
withtype2diabetescomplicatedbycomor-
bid hypertension and hyperlipidemia, put-
ting them at very high risk for arterial
stiffness and the consequent cardiovascular
risksassociatedwiththiscondition.Despite
having multiple cardiovascular risk factors,
we were able to show a signiﬁcant decrease
in both radial and femoral PWV. This is es-
pecially important with respect to femoral
PWV, one of the few measures directly
linked with cardiovascular mortality and
morbidity (14). Although there have been
some proposed pharmacological treat-
mentsforarterialstiffness(23),theresultsof
thecurrentstudyindicatethataerobicexer-
Figure 2—The 3-month training program did not result in a signiﬁcant increase in VO2max (P 
0.026) in the aerobic group (AT, f) or nonaerobic (NA,  )group.
Table 2 —Change in ﬁtness measures after intervention

 for AT subjects 
 for NA subjects P (time  group) P (time  group  sex)
Weight (kg) 0.082  0.732 0.140  0.364 0.942 0.103
BMI (kg/m
2) 0.23  0.28 0.05  0.17 0.396 0.137
Waist-to-hip ratio 0.002  0.007 0.002  0.011 0.786 0.854
SBP (mmHg) 10  5 2  3 0.171 0.567
DBP (mmHg) 5  2 1  2 0.091 0.396
MAP (mmHg) 7  3 1  3 0.078 0.906
Heart rate (bpm) 5.4  2.7 0.4  1.1 0.073 0.103
Fasting blood glucose (mEq) 0.8  0.3 0.1  0.2 0.098 0.698
Data are means  SEM. Changes in measures of ﬁtness for aerobically trained (AT) and untrained (NA) subjects are shown. None of these measures showed a
signiﬁcant training effect (time  group) because our study was only powered to ﬁnd an effect for our three primary outcomes. There was also no signiﬁcant
interaction of gender (time  group  sex) with the effects of training.
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duce arterial stiffness in older adults with
type 2 diabetes, even if the patient has ad-
ditional cardiovascular risk factors such as
hypertension and hypercholesterolemia.
Limitations
Further research is needed to determine
thepathophysiologicalmechanismforthe
reduction in radial and femoral PWV with
aerobic exercise in our population. We also
do not know if the observed improvements
inarterialstiffnesswithaerobicexerciseper-
sistoverlongerperiodsoftime,becauseour
subjects were only examined during the
3-month training period.
Our study was unable to detect any
signiﬁcant training effect on weight, BMI,
waist circumference, and fasting blood
glucose.Themainreasonisthatourstudy
was only powered to detect three primary
outcome measures (radial PWV, femoral
PWV, and VO2max). However, because fe-
male sex has been associated with lower
aerobic endurance in subjects with type 2
diabetes(24),thereisthepossibilitythata
signiﬁcanttrainingeffectwasobscuredby
sex differences. Congruent with the most
recent meta-analysis literature (25), we did
not detect any signiﬁcant interaction be-
tween sex and the effects of training on
weight, BMI, waist circumference, and fast-
ing blood glucose (Table 2). This observed
lack of a sex effect needs to be interpreted
with caution because our study had insufﬁ-
cient numbers to adequately assess sex dif-
ferences in the training response.
Becauseourexerciseinterventionwas
completedbyarelativelysmallnumberof
subjects, the beneﬁts of aerobic training
onarterialstiffnessneedtobeconﬁrmedby
largerstudies.Thefactthatashort3-month
intervention produced a sizable decrease in
arterialstiffnesssuggeststhatlargerexercise
studies in this high-risk group are practica-
ble and might be able to demonstrate train-
ing-induced improvements in mortality or
cardiovascular event rates.
In summary, we demonstrated that
aerobic exercise reduces multifactorial
(type2diabetes,aging,hypertension,and
hypercholesterolemia) arterial stiffness
with a relatively short intervention. Aero-
bic exercise should be ﬁrst-line therapy
for arterial stiffness, regardless of the un-
derlying etiology.
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